Last reviewed 2026-04-20 · How we verify

Phase 1b: LB-LR1109 and Atezolizumab

LG Chem · Phase 1 active Small molecule Quality 0/100

Phase 1b: LB-LR1109 and Atezolizumab is a Small molecule drug developed by LG Chem. It is currently in Phase 1 development.

At a glance

Generic name	Phase 1b: LB-LR1109 and Atezolizumab
Sponsor	LG Chem
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Phase 1b: LB-LR1109 and Atezolizumab CI brief — competitive landscape report
Phase 1b: LB-LR1109 and Atezolizumab updates RSS · CI watch RSS
LG Chem portfolio CI

Frequently asked questions about Phase 1b: LB-LR1109 and Atezolizumab

What is Phase 1b: LB-LR1109 and Atezolizumab?

Phase 1b: LB-LR1109 and Atezolizumab is a Small molecule drug developed by LG Chem.

Who makes Phase 1b: LB-LR1109 and Atezolizumab?

Phase 1b: LB-LR1109 and Atezolizumab is developed by LG Chem (see full LG Chem pipeline at /company/lg-chem).

What development phase is Phase 1b: LB-LR1109 and Atezolizumab in?

Phase 1b: LB-LR1109 and Atezolizumab is in Phase 1.

Manufacturer: LG Chem — full pipeline
Compare: Phase 1b: LB-LR1109 and Atezolizumab vs similar drugs
Pricing: Phase 1b: LB-LR1109 and Atezolizumab cost, discount & access